|
1
|
Rosenthal N: Regulation of gene
expression. N Engl J Med. 331:931–933. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krijger PH and De Laat W: Regulation of
disease-associated gene expression in the 3D genome. Nat Rev Mol
Cell Biol. 17:771–782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lopez AJ: Alternative splicing of
pre-mRNA: Developmental consequences and mechanisms of regulation.
Annu Rev Genet. 32:279–305. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hong H, Braunschweig U,
Gonatopoulos-Pournatzis T, Weatheritt RJ, Hirsch CL, Ha KCH,
Radovani E, Nabeel-Shah S, Sterne-Weiler T, Wang J, et al:
Multilayered control of alternative splicing regulatory networks by
transcription factors. Mol Cell. 65:539–553.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Talavera D, Orozco M and de la Cruz X:
Alternative splicing of transcription factors' genes: Beyond the
increase of proteome diversity. Comp Funct Genomics. 2009:Article
ID 9058942009. View Article : Google Scholar
|
|
6
|
Singh B and Eyras E: The role of
alternative splicing in cancer. Transcription. 8:91–98. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim YJ and Kim HS: Alternative splicing
and its impact as a cancer diagnostic marker. Genomics Inform.
10:74–80, 2017. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hofstetter G, Berger AH, Slade N, Zorić A,
Holzer B, Schuster E, Schuster E, Mobus VJ, Reimer D, Daxenbichler
G, et al: Alternative splicing of p53 and p73: The novel p53 splice
variant p53delta is an independent prognostic marker in ovarian
cancer. Oncogene. 29:1997–2004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hironori K, Takao I, Hiroaki I, Masafumi
T, Ken M and Hideyuki O: Neural RNA-binding protein Musashi1
inhibits translation initiation by competing with eIF4G for PABP. J
Cell Biol. 181:639–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Imai T, Tokunaga A, Yoshida T, Hashimoto
M, Mikoshiba K, Weinmaster G, Nakafuku M and Okano H: The neural
RNA-binding protein Musashi1 translationally regulates mammalian
numb gene expression by interacting with its mRNA. Mol Cell Biol.
21:3888–3900. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen HY, Lin LT, Wang ML, Lee SH, Tsai ML,
Tsai CC, Liu WH, Chen TC, Yang YP, Lee YY, et al: Musashi-1
regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and
chemoresistance in glioblastoma. Oncotarget. 7:42485–42501.
2016.PubMed/NCBI
|
|
12
|
Rezza A, Skah S, Roche C, Nadjar J,
Samarut J and Plateroti M: The overexpression of the putative gut
stem cell marker Musashi-1 induces tumorigenesis through Wnt and
Notch activation. J Cell Sci. 123:3256–3265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Toda M, Iizuka Y, Yu W, Imai T, Ikeda E,
Yoshida K, Kawase T, Kawakami Y, Okano H and Uyemura K: Expression
of the neural RNA-binding protein Musashi1 in human gliomas. Glia.
34:1–7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishimoto Y and Okano H: New insight into
cancer therapeutics: Induction of differentiation by regulating the
Musashi/Numb/Notch pathway. Cell Res. 20:1083–1085. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo
B, Okano H, Penalva LO and Glazer RI: Musashi1 as a potential
therapeutic target and diagnostic marker for lung cancer.
Oncotarget. 4:739–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi H, Pu J, Zhou XL, Ning YY and Bai C:
Silencing long non-coding RNA ROR improves sensitivity of
non-small-cell lung cancer to cisplatin resistance by inhibiting
PI3K/Akt/mTOR signaling pathway. Tumour Biol. 39:2017. View Article : Google Scholar
|
|
17
|
Li X, You M, Liu YJ, Ma L, Jin PP, Zhou R,
Zhang ZX, Hua B, Ji XJ, Cheng XY, et al: Reversal of the apoptotic
resistance of non-small-cell lung carcinoma towards TRAIL by
natural product toosendanin. Sci Rep. 7:427482017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui R, Zhang H, Guo X, Cui Q, Wang J and
Dai J: Proteomic analysis of cell proliferation in a human hepatic
cell line (HL-7702) induced by perfluorooctane sulfonate using
iTRAQ. J Hazard Mater. 299:361–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wan C, Gong C, Ji L, Liu X, Wang Y, Wang
L, Shao M, Yang L, Fan S, Xiao Y, et al: NF45 overexpression is
associated with poor prognosis and enhanced cell proliferation of
pancreatic ductal adenocarcinoma. Mol Cell Biochem. 410:25–35.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muz B, de la Puente P, Azab F and Azab AK:
The role of hypoxia in cancer progression, angiogenesis,
metastasis, and resistance to therapy. Hypoxia (Auckl). 3:83–92.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okano H, Kawahara H, Toriya M, Nakao K,
Shibata S and Imai T: Function of RNA-binding protein Musashi-1 in
stem cells. Exp Cell Res. 306:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiou GY, Yang TW, Huang CC, Tang CY, Yen
JY, Tsai MC, Chen HY, Fadhilah N, Lin CC and Jong YJ: Musashi-1
promotes a cancer stem cell lineage and chemoresistance in
colorectal cancer cells. Sci Rep. 7:21722017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao W, Li Y and Zhang X: Stemness-related
markers in cancer. Cancer Transl Med. 3:87–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Battelli C, Nikopoulos GN, Mitchell JG and
Verdi JM: The RNA-binding protein Musashi-1 regulates neural
development through the translational repression of p21WAF-1. Mol
Cell Neurosci. 31:85–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong J, Liu Z, Zhu H, Zhang X, Liang Y,
Yao S, Wang F, Xie X, Zhang B, Tan T, et al: The tumor suppressive
role of NUMB isoform 1 in esophageal squamous cell carcinoma.
Oncotarget. 5:5602–5614. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang Y, Ding M, Tian G, Guo H, Wan Y, Yao
Z, Li B and Lin D: Overexpression of Numb suppresses tumor cell
growth and enhances sensitivity to cisplatin in epithelioid
malignant pleural mesothelioma. Oncol Rep. 30:313–319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chilosi M, Doglioni C, Magalini A,
Inghirami G, Krampera M, Nadali G, Rahal D, Pedron S, Benedetti A,
Scardoni M, et al: p21/WAF1 cyclin-kinase inhibitor expression in
non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor
gene function. Blood. 88:4012–4020. 1996.PubMed/NCBI
|
|
28
|
Wolfe AR, Ernlund A, Mcguinness W, Lehmann
C, Carl K, Balmaceda N and Neufeld KL: Suppression of intestinal
tumorigenesis in Apc mutant mice upon Musashi-1 deletion. J Cell
Sci. 130:805–813. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maris C, Dominguez C and Allain FH: The
RNA recognition motif, a plastic RNA-binding platform to regulate
post-transcriptional gene expression. FEBS J. 272:2118–2131. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pastore C, Topalidou I, Forouhar F, Yan
AC, Levy M and Hunt JF: Crystal structure and RNA binding
properties of the RNA recognition motif (RRM) and AlkB domains in
human AlkB homolog 8 (ABH8), an enzyme catalyzing tRNA
hypermodification. J Biol Chem. 287:2130–2143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giampietri C, Petrungaro S, Conti S,
Facchiano A, Filippini A and Ziparo E: Cancer microenvironment and
endoplasmic reticulum stress response. Mediators Inflamm.
2015:4172812015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Urra H, Dufey E, Avril T, Chevet E and
Hetz C: Endoplasmic reticulum stress and the hallmarks of cancer.
Trends Cancer. 2:252–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sullivan R, Paré GC, Frederiksen LJ,
Semenza GL and Graham CH: Hypoxia-induced resistance to anticancer
drugs is associated with decreased senescence and requires
hypoxia-inducible factor-1 activity. Mol Cancer Ther. 7:1961–1973.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schnitzer SE, Weigert A, Zhou J and Brüne
B: Hypoxia enhances sphingosine kinase 2 activity and provokes
sphingosine-1-phosphate-mediated chemoresistance in A549 lung
cancer cells. Mol Cancer Res. 7:393–401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lan L, Appelman C, Smith AR, Yu J, Larsen
S, Marquez RT, Liu H, Wu X, Gao P, Roy A, et al: Natural product
(−)-gossypol inhibits colon cancer cell growth by targeting
RNA-binding protein Musashi-1. Mol Oncol. 9:1406–1420. 2015.
View Article : Google Scholar : PubMed/NCBI
|
